SLC1A2 and amyotrophic lateral sclerosis: Defects in glutamate transport are well-documented in ALS and a specific decrease in EAAT2/GLT1 levels has been observed in ALS patient samples and the SOD1 mouse model, though the cause of this defect remains elusive (Robberecht and Philips, 2013).